Sign inGet started

Byrne Thomas S

Insider CIK 1663220 · RESX General Counsel, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DFFN Diffusion Pharmaceuticals A Award deriv2020-01-072020-01-0925,000— $025,000SEC↗
DFFN Diffusion Pharmaceuticals A Award deriv2019-01-032019-01-302,667— $02,667SEC↗
DFFN Diffusion Pharmaceuticals A Award deriv2018-01-022018-01-0410,000— $010,000SEC↗
DFFN Diffusion Pharmaceuticals A Award deriv2017-01-032017-01-044,673— $04,673SEC↗
DFFN Diffusion Pharmaceuticals A Award deriv2016-05-162016-05-2016,667— $016,667SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-1236,526— $036,526SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12215,506— $0215,506SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-1291,316— $091,316SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12109,579— $0109,579SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12237,422— $0237,422SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12182,632— $0182,632SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12182,632— $0182,632SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12182,632— $0182,632SEC↗
RESX RestorGenex Corp A Award deriv2016-01-082016-01-12365,265— $0365,265SEC↗
RESX RestorGenex Corp A Award2016-01-082016-01-121,391,867— $01,391,867SEC↗